[
    {
        "file_name": "FIBROGENINC_10_01_2014-EX-10.11-COLLABORATIONAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Inconsistencies - In Text Contradiction",
                "original_text": "9.3 Payment. Any payments to be made with respect to the transfer of any Lead Compound in accordance with Section 9.1 or 9.2 above shall be immediately due to FG upon shipment, which shall be paid by Astellas to FG no later than [ * ] of the date of invoice, which invoice FG shall deliver to Astellas upon Delivery of Lead Compound to Astellas pursuant to Section 9.2(a), (b) or (c), and shall be made in U.S. dollars.",
                "changed_text": "9.3 Payment. Any payments to be made with respect to the transfer of any Lead Compound in accordance with Section 9.1 or 9.2 above shall be due to FG within [ * ] of the end of the calendar quarter in which shipment occurred, which invoice FG shall deliver to Astellas, and shall be paid by Astellas to FG no later than [ * ] days after Astellas’s receipt of invoice from FG, such invoices shall be made in U.S. dollars.",
                "explanation": "This introduces a contradiction by altering the payment terms. The original text states that payment is immediately due upon shipment, while the modified text gives [ * ] of the date of invoice for payment, creating uncertainty about the actual payment deadline.",
                "location": "Section 9.3"
            },
            {
                "type": "Inconsistencies - In Text Contradiction",
                "original_text": "10.2 Payment Method. All payments under this Agreement shall be made by bank wire transfer in immediately available funds to an account designated by the payee. All such payments made by or on behalf of Astellas hereunder shall be made by a Japanese entity. All dollar amounts specified in this Agreement, and, except as specifically authorized under Section 10.3 hereof, all payments made hereunder, are and shall be made in U.S. dollars. Any payments due under this Agreement which are not paid by the date such payments are due under this Agreement shall bear interest to the extent permitted by applicable law at the U.S. prime rate per annum quoted in the \"Money Rates\" column of The Wall Street Journal (U.S., Western Edition) on the first business day after such payment is due, plus an additional [ * ], calculated on the number of days such payment is delinquent. This Section 10.2 shall in no way limit any other remedies available to either party.",
                "changed_text": "10.2 Payment Method. All payments under this Agreement shall be made by bank wire transfer in immediately available funds to an account designated by the payee. All such payments made by or on behalf of Astellas hereunder shall be made by a Japanese entity. All dollar amounts specified in this Agreement, and, except as specifically authorized under Section 10.3 hereof, all payments made hereunder, are and shall be made in U.S. dollars. Payments more than 30 days past due are subject to a 10% interest charge. This Section 10.2 shall in no way limit any other remedies available to either party.",
                "explanation": "The original text specified that late payments would accrue interest at a rate based on the U.S. prime rate plus an additional [ * ]. The modified text changes the late payment interest penalty to be a flat 10% rate for payments more than 30 days past due. This contradiction could lead to disputes about the applicable interest rate.",
                "location": "Section 10.2"
            },
            {
                "type": "Inconsistencies - In Text Contradiction",
                "original_text": "6.1 Payments for Reimbursement; Net Payments. FG hereby acknowledges receipt of U.S. $[ * ] on February 13, 2004, U.S. $[ * ] on January 28, 2005, and U.S. $[ * ] on March 22, 2005 as initial payments for reimbursement of historical research and development expenditures for the Lead Compounds. Astellas agrees to pay to FG the amounts set forth in Section 6.1.1 below. The parties hereto acknowledge that the Development Program hereunder involves a high degree of risk and uncertainty; accordingly, both parties hereto expressly disclaim any implied warranty as to the results of the Development Program.",
                "changed_text": "6.1 Payments for Reimbursement; Net Payments. FG hereby acknowledges receipt of U.S. $[ * ] on February 13, 2004, U.S. $[ * ] on January 28, 2005, and U.S. $[ * ] on March 22, 2005 as initial payments for reimbursement of historical research and development expenditures for the Lead Compounds. Astellas has no further payment obligations under this agreement. The parties hereto acknowledge that the Development Program hereunder involves a high degree of risk and uncertainty; accordingly, both parties hereto expressly disclaim any implied warranty as to the results of the Development Program.",
                "explanation": "The original states Astellas agrees to pay amounts set forth in Section 6.1.1 below. The change removes Astellas's agreement to pay the amounts set forth in Section 6.1.1 and replace it with, “Astellas has no further payment obligations under this agreement”, creating a direct conflict.",
                "location": "Section 6.1"
            }
        ]
    }
]